Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1382
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines

Zhou Y, Li K, Zhang S, Li Q, Li Z, Zhou F, Dong X, Liu L, Wu G, Meng R

Year : 2015| Volume: 52| Issue : 6 | Page no: 119-124

   This article has been cited by
 
1 A CobaltII/CobaltIII complex of alizarin that was analyzed from the stand point of binding with DNA, for ROS generation and anticancer drug prospecting was identified as an analogue of anthracyclines
Mouli Saha, Soumen Singha, Deblina Ghosh, Sanjay Kumar, Parimal Karmakar, Saurabh Das
Journal of Molecular Structure. 2022; : 133011
[Pubmed]  [Google Scholar] [DOI]
2 Evaluation of Biological Activity of a Diazocine Derivative against Heart Failure Using an Ischemia-Reperfusion Injury Model
Figueroa-Valverde Lauro, Rosas-Nexticapa Marcela, López-Ramos Maria, Alvarez-Ramirez Magdalena, Mateu-Armad Maria Virginia, Díaz-Cedillo Francisco, Garcimarrero-Espino Alejandra, Lopez Gutierrez Tomas, Melgarejo-Gutierrez Montserrat
Drug Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Molecular mechanisms of quinalizarin induces apoptosis and G0 / G1 cell cycle of human esophageal cancer HCE -4 cells depends on MAPK ,
Yan-Qing Zang, Yu-Qing Zhai, Yan-Yu Feng, Xue-Ying Ju, Feng Zuo
Environmental Toxicology. 2021; 36(2): 276
[Pubmed]  [Google Scholar] [DOI]
4 New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation
Eman T. Warda, Ihsan A. Shehata, Mahmoud B. El-Ashmawy, Nadia S. El-Gohary
Bioorganic & Medicinal Chemistry. 2020; 28(21): 115674
[Pubmed]  [Google Scholar] [DOI]
5 Quinalizarin induces ROS-mediated apoptosis via the MAPK, STAT3 and NF-?B signaling pathways in human breast cancer cells
Yan-Qing Zang, Yan-Yu Feng, Ying-Hua Luo, Yu-Qing Zhai, Xue-Ying Ju, Yu-Chao Feng, Ya-Nan Sheng, Jia-Ru Wang, Chang-Qing Yu, Cheng-Hao Jin
Molecular Medicine Reports. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 A meta-analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR-193a-5p in lung cancer
Zu-Cheng Xie, Rui-Xue Tang, Xiang Gao, Qiong-Ni Xie, Jia-Ying Lin, Gang Chen, Zu-Yun Li
Oncology Letters. 2018;
[Pubmed]  [Google Scholar] [DOI]
7 Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT-4 and HCT 116 Cells
Sayantani Mukherjee Chatterjee,Chetan Kumar Jain,Soumen Singha,Piyal Das,Susanta Roychoudhury,Hemanta Kumar Majumder,Saurabh Das
ACS Omega. 2018; 3(8): 10255
[Pubmed]  [Google Scholar] [DOI]
8 Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer
Qianwen Li,Ke Li,Tianyang Yang,Sheng Zhang,Yu Zhou,Zhenyu Li,Jinrong Xiong,Fangzheng Zhou,Xiaoshu Zhou,Li Liu,Rui Meng,Gang Wu
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
9 Sphingosine kinase 1 mediates diabetic renal fibrosis via NF-?B signaling pathway: involvement of CK2a
Junying Huang, Jingyan Li, Zhiquan Chen, Jie Li, Qiuhong Chen, Wenyan Gong, Peiqing Liu, Heqing Huang
Oncotarget. 2017; 8(51): 88988
[Pubmed]  [Google Scholar] [DOI]
10 CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa Chua,Charina Ortega,Ayesha Sheikh,Migi Lee,Hussein Abdul-Rassoul,Kevan Hartshorn,Isabel Dominguez
Pharmaceuticals. 2017; 10(4): 18
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow